We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $5.01B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+10.05%
1 Year Est. Return
+6.26%
3 Year Est. Return
+35.56%
5 Year Est. Return
+47.32%
10 Year Est. Return
+493.31%
AUM
$1.24B
AUM Growth
-$10.3M
Cap. Flow
-$117M
Cap. Flow %
-9.46%
Top 10 Hldgs %
33.81%
Holding
118
New
9
Increased
14
Reduced
70
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 26.89%
2 Technology 26.58%
3 Industrials 16.02%
4 Materials 5.08%
5 Consumer Discretionary 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STMP
1
DELISTED
Stamps.com, Inc.
STMP
$55.4M 4.48%
505,464
-48,957
-9% -$4.49M
TYL icon
2
Tyler Technologies
TYL
$13.1B
$44.3M 3.58%
253,915
-52,168
-17% -$9.02M
NEOG icon
3
Neogen
NEOG
$2.24B
$42.1M 3.4%
1,987,109
-194,312
-9% -$3.96M
BLKB icon
4
Blackbaud
BLKB
$1.49B
$42.1M 3.4%
639,451
-110,767
-15% -$6.93M
EPAY
5
DELISTED
Bottomline Technologies Inc
EPAY
$42M 3.4%
1,413,355
+42,755
+3% +$1.21M
OMCL icon
6
Omnicell
OMCL
$2.09B
$41.7M 3.37%
1,342,369
-57,777
-4% -$1.7M
CMD
7
DELISTED
Cantel Medical Corporation
CMD
$40.8M 3.3%
657,039
-292,126
-31% -$17.8M
SPSC icon
8
SPS Commerce
SPSC
$2.41B
$40.7M 3.29%
1,158,206
-92,718
-7% -$3.39M
AAON icon
9
Aaon
AAON
$9.13B
$35.6M 2.87%
2,296,964
-707,502
-24% -$10.7M
FLTX
10
DELISTED
Fleetmatics Group PLC
FLTX
$33.7M 2.72%
662,703
-66,047
-9% -$3.67M
MLAB icon
11
Mesa Laboratories
MLAB
$541M
$31.9M 2.58%
320,704
-11,271
-3% -$1.21M
PRLB icon
12
Protolabs
PRLB
$1.85B
$31.6M 2.55%
496,118
-45,884
-8% -$2.96M
ACIW icon
13
ACI Worldwide
ACIW
$5.9B
$31.3M 2.53%
1,463,348
-292,863
-17% -$6.74M
LGND icon
14
Ligand Pharmaceuticals
LGND
$6.08B
$31M 2.51%
458,718
-36,208
-7% -$2.24M
DORM icon
15
Dorman Products
DORM
$4.24B
$31M 2.5%
652,283
-55,091
-8% -$2.69M
CSGP icon
16
CoStar Group
CSGP
$12.2B
$29.9M 2.42%
1,446,960
-299,770
-17% -$5.97M
PRO
17
DELISTED
PROS Holdings
PRO
$29.7M 2.4%
1,289,306
-283,868
-18% -$6.59M
VASC
18
DELISTED
Vascular Solutions Inc
VASC
$29.4M 2.38%
856,111
+137,615
+19% +$4.66M
SSD icon
19
Simpson Manufacturing
SSD
$7.78B
$28.9M 2.34%
847,515
-64,992
-7% -$2.36M
HLIO icon
20
Helios Technologies
HLIO
$2.68B
$27.7M 2.24%
873,959
-75,924
-8% -$2.33M
EGOV
21
DELISTED
NIC Inc
EGOV
$27.2M 2.2%
1,383,140
-157,860
-10% -$3.09M
ALGN icon
22
Align Technology
ALGN
$12.7B
$27.1M 2.19%
411,848
-84,434
-17% -$5.42M
ABCO
23
DELISTED
Advisory Board Co
ABCO
$25.9M 2.09%
522,116
-132,929
-20% -$6.47M
HCSG icon
24
Healthcare Services Group
HCSG
$1.74B
$25.9M 2.09%
741,846
-69,789
-9% -$2.54M
BCPC
25
Balchem Corp
BCPC
$5.25B
$25.6M 2.07%
421,023
-117,352
-22% -$7.62M

Similar funds

Conestoga Capital Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Conestoga Capital Advisors held 118 positions worth $1.24B, down 0.83% from $1.25B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Conestoga Capital Advisors withdrew a net $117M in Q4 2015, closing 4 positions and reducing 70 holdings. Its most notable exit was Hibbett, Inc. Common Stock, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Conestoga Capital Advisors opened a new position in WageWorks, Inc. worth $5.9M.

  • Conestoga Capital Advisors's largest Q4 2015 buy was WageWorks, Inc.: 130,101 shares worth $5.9M.
  • Conestoga Capital Advisors added most to Exponent in Q4 2015, an estimated $15.7M increase.
  • Conestoga Capital Advisors's biggest Q4 2015 reduction was Cantel Medical Corporation, cutting an estimated $17.8M.
  • Conestoga Capital Advisors fully exited Hibbett, Inc. Common Stock in Q4 2015, selling an estimated $10.7M.
  • Conestoga Capital Advisors's ten largest holdings make up 34% of its $1.24B portfolio in Q4 2015.
  • Conestoga Capital Advisors opened 9 new positions and closed 4 in Q4 2015.
  • Conestoga Capital Advisors's portfolio value fell 0.83% quarter-over-quarter to $1.24B.

Based on Conestoga Capital Advisors's 13F filing for Q4 2015, filed 14 Jan 2016.